Piper Sandler Maintains Neutral on Enfusion, Raises Price Target to $11.5
Piper Sandler Maintains Enfusion(ENFN.US) With Hold Rating, Raises Target Price to $11.5
Enfusion (ENFN) Receives a Hold From Piper Sandler
12 Information Technology Stocks Moving In Thursday's Pre-Market Session
Stifel Maintains Enfusion(ENFN.US) With Buy Rating, Raises Target Price to $13
Enfusion Is Maintained at Buy by Stifel
Enfusion Analyst Ratings
Microsoft and More Big Software Names Look to Grow in 2025 on AI Monetization: Stifel
Have Insiders Sold Enfusion Shares Recently?
Enfusion To Present at Upcoming Investor Events
An Intrinsic Calculation For Enfusion, Inc. (NYSE:ENFN) Suggests It's 38% Undervalued
There May Be Some Bright Spots In Enfusion's (NYSE:ENFN) Earnings
Morgan Stanley Maintains Enfusion(ENFN.US) With Buy Rating, Maintains Target Price $11
Stifel Maintains Enfusion(ENFN.US) With Buy Rating, Raises Target Price to $11
Enfusion | 10-Q: Q3 2024 Earnings Report
Enfusion: Strong Client Acquisitions and Strategic Positioning Drive Buy Rating
Enfusion Price Target Raised to $11 From $10 at Stifel
Enfusion, Inc. (ENFN) Q3 2024 Earnings Call Transcript Summary
Enfusion, Inc. (ENFN) Q3 2024 Earnings Call Transcript
William Blair Maintains Enfusion(ENFN.US) With Buy Rating